pergolide has been researched along with Schizophrenia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Braus, DF; Büchel, C; Diehl, A; Gattaz, WF; Krumm, B; Medori, R | 1 |
Mori, N; Nakamura, K; Sekine, Y; Suzuki, K; Takebayashi, K; Takei, N; Toulopoulou, T; Tsuchiya, KJ | 1 |
2 other study(ies) available for pergolide and Schizophrenia
Article | Year |
---|---|
[Tardive dyskinesia: pergolid, a possible therapeutic option].
Topics: Adult; Aged; Antipsychotic Agents; Cross-Over Studies; Dopamine Agonists; Double-Blind Method; Dyskinesia, Drug-Induced; Female; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neurologic Examination; Neuroprotective Agents; Pergolide; Pilot Projects; Schizophrenia; Treatment Outcome | 2003 |
Effective adjunctive use of pergolide with quetiapine for cognitive impairment and negative symptoms in schizophrenia.
Topics: Adult; Cognition Disorders; Dibenzothiazepines; Drug Therapy, Combination; Humans; Male; Pergolide; Quetiapine Fumarate; Schizophrenia; Schizophrenic Psychology | 2005 |